Larimar Therapeutics, Inc. (LRMR)
4.015
+0.08
(+1.90%)
USD |
NASDAQ |
Dec 11, 16:00
4.015
0.00 (0.00%)
After-Hours: 18:19
Larimar Therapeutics Market Cap: 343.65M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 19.82M |
| AIM ImmunoTech, Inc. | 1.120M |
| IGC Pharma, Inc. | 30.14M |
| NovaBay Pharmaceuticals, Inc. | 361.65M |
| Protalix Biotherapeutics, Inc. | 146.37M |
Market Cap Related Metrics
| PEG Ratio | -0.0309 |
| Price to Book Value | 2.472 |
| Price | 4.015 |
| Earnings Yield | -48.01% |
| PEGY Ratio | -0.0309 |